The chart below shows what happened during the study.
Before the participants took study treatment
1 visit
The study doctors:
checked the health of the participants to took blood and urine samples
make sure they could join the study
did a physical exam and asked about checked the participants’ heart health using
the participants’ medications and any an electrocardiogram, also called an ECG
medical problems
checked the participants’ eye health using
checked how well the participants were
a special microscope for looking in eyes
able to carry out their daily activities
checked that the participants had the
“EGFR T790M positive” mutation in
their tumors
Up to 4 weeks
While the participants took study treatment
Visits every 6 weeks
The study doctors:
did a physical exam and asked about checked the participants’ heart health
the participants’ medications and using an ECG if needed
any medical problems
checked the participants’ eye health using
checked how well the participants were a special microscope for looking in eyes
able to carry out their daily activities if needed
took blood and urine samples if needed The participants:
took osimertinib at home once a day
For as long as the study doctors thought osimertinib was helping the participants
After the participants took study treatment
Visits every 6 weeks
The study doctors:
checked the participants’ health and asked about their medications and any medical problems
Until the study ended
6 | Clinical Study Results